Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Mol Cancer Res. 2021 May 26;19(9):1510–1521. doi: 10.1158/1541-7786.MCR-21-0053

Fig. 2. Genomic characterization of the study cohort.

Fig. 2.

The oncoprint shows the most common nonsynonymous somatic mutations in cancer-associated genes identified by exome-sequencing. The top bars represent the number of variants identified in each sample, while the side bars represent the number (and percent) of individuals displaying mutations in each gene. The bottom tiles contain additional genomic and clinical information evaluated as part of this study.